Mandeep Chawla sold $6.0M of CLS
Chief Financial Officer at CELESTICA INC. 16,117 shares at an average of $369.32, traded Aug 4, 2026, filed Aug 6, 2026.
Score components
- +22RoleCFO
- +25Trade size$6.0M at market
- +5Share of holdings soldSold 20% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-338761, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 4, 2026 | SOpen-market sale Common Shares10b5-1 | -1,534 | $360.18 | $553k | 80,027 | Aug 6, 2026 |
| Aug 4, 2026 | SOpen-market sale Common Shares10b5-1 | -280 | $361.56 | $101k | 79,747 | Aug 6, 2026 |
| Aug 4, 2026 | SOpen-market sale Common Shares10b5-1 | -240 | $362.50 | $87k | 79,507 | Aug 6, 2026 |
| Aug 4, 2026 | SOpen-market sale Common Shares10b5-1 | -960 | $363.50 | $349k | 78,547 | Aug 6, 2026 |
| Aug 4, 2026 | SOpen-market sale Common Shares10b5-1 | -520 | $364.58 | $190k | 78,027 | Aug 6, 2026 |
| Aug 4, 2026 | SOpen-market sale Common Shares10b5-1 | -320 | $365.55 | $117k | 77,707 | Aug 6, 2026 |
| Aug 4, 2026 | SOpen-market sale Common Shares10b5-1 | -480 | $366.61 | $176k | 77,227 | Aug 6, 2026 |
| Aug 4, 2026 | SOpen-market sale Common Shares10b5-1 | -1,080 | $367.56 | $397k | 76,147 | Aug 6, 2026 |
| Aug 4, 2026 | SOpen-market sale Common Shares10b5-1 | -1,200 | $368.56 | $442k | 74,947 | Aug 6, 2026 |
| Aug 4, 2026 | SOpen-market sale Common Shares10b5-1 | -400 | $369.24 | $148k | 74,547 | Aug 6, 2026 |
| Aug 4, 2026 | SOpen-market sale Common Shares10b5-1 | -120 | $370.60 | $44k | 74,427 | Aug 6, 2026 |
| Aug 4, 2026 | SOpen-market sale Common Shares10b5-1 | -1,277 | $371.67 | $475k | 73,150 | Aug 6, 2026 |
| Aug 4, 2026 | SOpen-market sale Common Shares10b5-1 | -4,185 | $372.45 | $1.6M | 68,965 | Aug 6, 2026 |
| Aug 4, 2026 | SOpen-market sale Common Shares10b5-1 | -2,761 | $373.42 | $1.0M | 66,204 | Aug 6, 2026 |
| Aug 4, 2026 | SOpen-market sale Common Shares10b5-1 | -760 | $374.16 | $284k | 65,444 | Aug 6, 2026 |
Related signals
Other insiders at CELESTICA INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 58Moderate | CELESTICA INC | Robert Mionis Chief Executive Officer | $8.5M 23,396 shares | -100% | |
| 38Weak | CELESTICA INC | Todd C Cooper President | $7.2M 20,118 shares | -22% | |
| 58Moderate | CELESTICA INC | Robert Mionis Chief Executive Officer | $8.5M 23,496 shares | -50% | |
| 58Moderate | CELESTICA INC | Robert Mionis Chief Executive Officer | $36M 98,453 shares | -194% | |
| 58Moderate | CELESTICA INC | Robert Mionis Chief Executive Officer | $19M 51,061 shares | -52% | |
| 24Weak | CELESTICA INC | Mandeep Chawla Chief Financial Officer | $324k 883 shares | -1% | |
| 43Moderate | CELESTICA INC | Robert Mionis Chief Executive Officer | $3.5M 9,543 shares | -16% | |
| 40Moderate | CELESTICA INC | Mandeep Chawla Chief Financial Officer | $6.8M 17,000 shares | -17% | |
| 48Moderate | CELESTICA INC | Robert Mionis Chief Executive Officer | $26M 66,056 shares | -33% | |
| 48Moderate | CELESTICA INC | Robert Mionis Chief Executive Officer | $22M 55,768 shares | -42% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.